← FDA Drug Approvals (Drugs@FDA)

SOLOSEC

NDA · New Drug Application · Sponsor: EVOFEM INC · Approved 2017-09-15

Drug application

FDA Application #

NDA209363

Application type

New Drug Application

Brand name

SOLOSEC

Generic name

SECNIDAZOLE

Active ingredients

SECNIDAZOLE

Dosage form

GRANULE

Route

ORAL

Marketing status

Prescription

Sponsor

EVOFEM INC

Manufacturer

Evofem Inc.

First approval

2017-09-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown